India's NPPA targets international cardiac stent makers for meeting on product price data

SINGAPORE--India's National Pharmaceutical Pricing Authority ordered international makers of cardiac stents to meet with the agency Feb. 25 after several companies failed to submit data about the price of their products.

A letter over the signature of Assistant Director Babita Singh was circulated to device maker offices in New Delhi just two days before the meeting. They included such giants as Abbott ($ABT), Boston Scientific ($BSX), Edwards Lifesciences ($EW), Johnson & Johnson ($JNJ) and Medtronic ($MDT).

All of the notified companies locally produce or import devices in the NPPA category of Cardiac Stents & Drug-Eluting Stents. Two issues on the table would be stent pricing and the availability of them in India, the letter said.

Facing a deadline for establishing prices, the agency had sent at least two other notices to the device makers this month reminding them that pricing information was due.

- here's the NPPA letter (PDF)